255 related articles for article (PubMed ID: 19239931)
1. [Rationale for perioperative chemotherapy treatment in peritoneal carcinomatosis].
Barrasa A; Van de Speeten K; Anthony Stuart O; Hendrick Sugarbaker P; Zappa L
Cir Esp; 2009 Jan; 85(1):3-13. PubMed ID: 19239931
[TBL] [Abstract][Full Text] [Related]
2. Strategies for management of the peritoneal surface component of cancer: cytoreductive surgery plus perioperative intraperitoneal chemotherapy.
Sugarbaker PH; Stuart OA; Yoo D
J Oncol Pharm Pract; 2005 Sep; 11(3):111-9. PubMed ID: 16390599
[TBL] [Abstract][Full Text] [Related]
3. Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis.
Detroz B; Laurent S; Honoré P; Blaffart F; Limet R; Meurisse M
Acta Chir Belg; 2004 Aug; 104(4):377-83. PubMed ID: 15469146
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive management of peritoneal surface malignancy using cytoreductive surgery and perioperative intraperitoneal chemotherapy: the Washington Cancer Institute approach.
Sugarbaker PH
Expert Opin Pharmacother; 2009 Aug; 10(12):1965-77. PubMed ID: 19563273
[TBL] [Abstract][Full Text] [Related]
5. Using pharmacologic data to plan clinical treatments for patients with peritoneal surface malignancy.
Van der Speeten K; Stuart OA; Sugarbaker PH
Curr Drug Discov Technol; 2009 Mar; 6(1):72-81. PubMed ID: 19275544
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of perioperative cancer chemotherapy in peritoneal surface malignancy.
Van der Speeten K; Stuart OA; Sugarbaker PH
Cancer J; 2009; 15(3):216-24. PubMed ID: 19556908
[TBL] [Abstract][Full Text] [Related]
7. Perioperative outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy for non-appendiceal peritoneal carcinomatosis from a prospective database.
Yan TD; Zappa L; Edwards G; Alderman R; Marquardt CE; Sugarbaker PH
J Surg Oncol; 2007 Aug; 96(2):102-12. PubMed ID: 17221852
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of perioperative intraperitoneal and intravenous chemotherapy in patients with peritoneal surface malignancy.
Van der Speeten K; Stuart OA; Sugarbaker PH
Surg Oncol Clin N Am; 2012 Oct; 21(4):577-97. PubMed ID: 23021717
[TBL] [Abstract][Full Text] [Related]
9. Management of peritoneal carcinomatosis.
Sugarbaker PH
Acta Med Austriaca; 1989; 16(3-4):57-60. PubMed ID: 2514551
[TBL] [Abstract][Full Text] [Related]
10. Treatment of peritoneal carcinomatosis from colorectal cancer with cytoreductive surgery and perioperative intraperitoneal chemotherapy: state of the art and future prospects.
Di Carlo I; Pulvirenti E; Sparatore F; Toro A; Cordio S
Surg Oncol; 2007 Dec; 16 Suppl 1():S145-8. PubMed ID: 18023575
[TBL] [Abstract][Full Text] [Related]
11. [Surgical treatment of peritoneal carcinomatosis].
Elias D; Liberale G; Manganas D; Lasser P; Pocard M
Ann Chir; 2004 Nov; 129(9):530-3. PubMed ID: 15556586
[TBL] [Abstract][Full Text] [Related]
12. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal carcinomatosis: if at first you don't succeed...
Lambert LA; Mansfield PF
Ann Surg Oncol; 2007 Nov; 14(11):3037-9. PubMed ID: 17726635
[No Abstract] [Full Text] [Related]
13. [Intraperitoneal cisplatin plus epinephrine and surgical debulking for the treatment of advanced peritoneal carcinomatosis in the rat].
Benoit L; Duvillard C; Beltramo JL; Brunet-Lecomte P; Chauffert B
Gastroenterol Clin Biol; 2000 Jan; 24(1):26-30. PubMed ID: 10679584
[TBL] [Abstract][Full Text] [Related]
14. Management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy.
Gómez Portilla A; Barrios P; Rufian S; Camps B; Bretcha P; Gonzalez Bayon L; Torres Melero J; García Polavieja M; Gonzalez Moreno S
Eur J Surg Oncol; 2006 Aug; 32(6):628-31. PubMed ID: 16682169
[TBL] [Abstract][Full Text] [Related]
15. An evolving role of perioperative intraperitoneal chemotherapy after cytoreductive surgery for colorectal peritoneal carcinomatosis.
Yan TD; Sugarbaker PH
Ann Surg Oncol; 2007 Jul; 14(7):2171-2. PubMed ID: 17453299
[No Abstract] [Full Text] [Related]
16. Selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and perioperative intraperitoneal chemotherapy.
Yan TD; Sim J; Morris DL
Ann Surg Oncol; 2007 Jun; 14(6):1807-17. PubMed ID: 17342564
[TBL] [Abstract][Full Text] [Related]
17. Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy.
Sugarbaker PH; Mora JT; Carmignani P; Stuart OA; Yoo D
Oncologist; 2005 Feb; 10(2):112-22. PubMed ID: 15709213
[TBL] [Abstract][Full Text] [Related]
18. Cytoreductive surgery (cs) and hyperthermic intraperitoneal chemotherapy (hipec) in treatment of peritoneal surface malignances: report of a phase II clinical study.
Asero S; Caruso M; Vallone N; Luciani AG; Lombardo V; Terranova G; Ettore G; Giannone G
In Vivo; 2009; 23(4):645-7. PubMed ID: 19567402
[TBL] [Abstract][Full Text] [Related]
19. Evolution of cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis: are there treatment alternatives?
Sugarbaker PH
Am J Surg; 2011 Feb; 201(2):157-9. PubMed ID: 20870209
[No Abstract] [Full Text] [Related]
20. Strategies for the prevention and treatment of peritoneal carcinomatosis from gastrointestinal cancer.
Sugarbaker PH
Cancer Invest; 2005; 23(2):155-72. PubMed ID: 15813509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
